{'fraction_non_alphanumeric': 0.032670454545454544, 'fraction_numerical': 0.03125, 'mean_word_length': 5.0256410256410255, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Improvement of the Pre-Analytical Phase of Nasopharyngeal Samples During the COVID 19 Pandemic: Experience of the Institute Pasteur De Côte d’Ivoire in 2020

Introduction In late January 2020, the WHO declared the new Coronavirus disease 2019 (COVID-19) to be a public health emergency of international concern [1]. Africa, with a heterogeneity of economies, cultures and disease models, is fortunately the last continent to be affected by the pandemic [2]. Health systems in Africa are under strain and have minimal capacity to control the pandemic [3]. Early detection of the importation of COVID-19 is a crucial challenge for all countries at risk of importation from areas of active transmission [4].